At this moment in time, it's batting 1000. One child was treated (on a compassionate use basis prior to any clinical trial being started)resulting in a complete disease remission. Too soon IMO to call it a complete cure, but it sure is looking good.
Why do you believe it has little chance of success?
Thanks in advance, Ian
I have no position in Cellectis because I think it has low probability for success IMO.
Market Data 
Markets 
AI
